Topical Pain Relief Market Anticipated to Grow at 5.4% CAGR Through 2029: Industry Report

 By combining trend forecasting and competitive intelligence, this report supports future-focused strategy in the topical pain relief sector.

 

 What Is The Expected CAGR For The Topical Pain Relief Market Through 2025?
 The topical pain relief market size has grown strongly in recent years. It will grow from $10.74 billion in 2024 to $11.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to prevalence of chronic conditions, prevalence of sports-related injuries, understanding of online pharmacy, increase in prevalence of arthritis, increase in the number of older people.
 
 The topical pain relief market size is expected to see strong growth in the next few years. It will grow to $14.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing prevalence of joint pains and arthritis, increasing demand among athletes, increasing adoption of pain management devices and patches, e-commerce platform growth, rising drug development, rising healthcare costs. Major trends in the forecast period include increasing number of cancer patients, easy product availability, advent of home delivery models, increasing number of individuals participating in sports activities, innovation in formulations.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13744&type=smp
 
 Which Key Factors Will Influence Topical Pain Relief Market Growth Over 2025–2034?
 The growing prevalence of arthritis and bone-related disorders is expected to propel the growth of the topical pain relief market going forward. Arthritis and bone-related disorders encompass medical conditions that affect the joints, bones, and surrounding tissues. Topical pain relief is often used to manage arthritis and bone-related disorders to alleviate localized pain, inflammation, and discomfort associated with these conditions, particularly in more superficial joints. For instance, in February 2024, according to the Centers for disease control and prevention (CDC), a US-based health protection agency, in 2022, 18.9% of adults had arthritis, more common in women (21.5%) than men (16.1%). Prevalence increased with age, peaking at 53.9% in those 75 and older, and was higher among Black and White non-Hispanic adults. Rates decreased with higher income and in urban areas. Therefore, the growing prevalence of arthritis and bone-related disorders is driving the growth of the topical pain relief market.
 
 Comprehensive Segment-Wise Insights Into The Topical Pain Relief Market
 The topical pain reliefmarket covered in this report is segmented — 
 
 1) By Type: Prescription Pain Relief; Over-The-Counter (OTC) Pain Relief
 2) By Formulation: Cream; Gel; Spray; Patch; Other Formulations
 3) By Therapeutic: Non-Opioids; Opioids
 4) By Distribution Channel: Pharmacies And Drug Stores; E-Commerce; Retail And Grocery Stores
 
 Subsegments:
 1) By Prescription Pain Relief: Prescription Creams And Gels; Prescription Patches; Compounded Topical Analgesics 
 2) By Over-The-Counter (OTC) Pain Relief: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Counterirritants; Analgesic Creams And Gels
 
 
 Key Trends Driving Growth In The Topical Pain Relief Market
 Major companies operating in the topical pain relief market are focused on developing innovative products such as pain relieving cream to meet the growing demand for effective pain relief products. Pain relieving cream is an external cream that provides penetrating pain relief to help numb minor joint and muscle soreness. For instance, in August 2023, Kenvue Inc., a US-based consumer health company, launched a new topical pain-relieving cream called Tylenol, a precise pain-relieving cream. It is designed to provide maximum-strength lidocaine (4%) without a prescription. It comes in two formats: a rapid-absorbing formula and a uniquely designed rollerball for hands-free, no-mess application. The cream is fragrance-free and comes in fresh scent options for discreet use. Additionally, its features provide maximum-strength lidocaine for targeted and rapid pain relief, catering to consumers looking for effective and convenient solutions.
 
 Analysis Of Key Players In Topical Pain Relief Market
 Major companies operating in the topical pain relief market report are Pfizer Inc., Johnson & Johnson, Abbvie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Co., GlaxoSmithKline PLC, Acella Pharmaceuticals LLC, Eli Lilly and Company, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Galderma S.A., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Ltd., Lupin Limited, Almirall S.A., AdvaCare Pharma, Roivant Sciences Inc., Topical BioMedics Inc.
 
 View the full topical pain relief market report here:
 https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report
 
 What Are The Key Regional Trends In The Topical Pain Relief Market?
 North America was the largest region in the topical pain relief market in 2024. The regions covered in the topical pain relief market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company